Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study

R. J. Simes, Merryn Voysey, Rachel O'Connell, Paul P. Glasziou, James D. Best, Russell Scott, David R. Sullivan, Christian Ehnholm, Anthony C. Keech

Research output: Contribution to journal › Meeting Abstract › Research › peer-review

Fingerprint

Dive into the research topics of 'Larger Effects of Fenofibrate on CVD in Marked Diabetic Dyslipidemia Are Not Explained by Higher Use of Statin Therapy: The FIELD Study'. Together they form a unique fingerprint.

Medicine & Life Sciences